0.3179
price up icon4.49%   0.0039
 
loading
Oragenics Inc stock is traded at $0.3179, with a volume of 84,174. It is up +4.49% in the last 24 hours and down -21.88% over the past month. Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$0.314
Open:
$0.314
24h Volume:
84,174
Relative Volume:
0.10
Market Cap:
$3.31M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.0545
EPS:
-5.83
Net Cash Flow:
$-8.25M
1W Performance:
+3.21%
1M Performance:
-21.88%
6M Performance:
-69.34%
1Y Performance:
-91.34%
1-Day Range:
Value
$0.31
$0.3285
1-Week Range:
Value
$0.28
$0.3298
52-Week Range:
Value
$0.28
$7.74

Oragenics Inc Stock (OGEN) Company Profile

Name
Name
Oragenics Inc
Name
Phone
813-286-7900
Name
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Name
Employee
6
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
OGEN's Discussions on Twitter

Oragenics Inc Stock (OGEN) Latest News

pulisher
Nov 04, 2024

StockNews.com Initiates Coverage on Oragenics (NYSE:OGEN) - Defense World

Nov 04, 2024
pulisher
Oct 31, 2024

SEC Form DEF 14A filed by Oragenics Inc. - Quantisnow

Oct 31, 2024
pulisher
Oct 30, 2024

OGEN stock plunges to 52-week low, touches $0.28 By Investing.com - Investing.com Canada

Oct 30, 2024
pulisher
Oct 30, 2024

OGEN stock plunges to 52-week low, touches $0.28 - Investing.com

Oct 30, 2024
pulisher
Oct 27, 2024

Oragenics (NYSE:OGEN) Now Covered by Analysts at StockNews.com - Defense World

Oct 27, 2024
pulisher
Oct 21, 2024

Oragenics, Inc. to Present at the Centurion One Capital 2nd Annual Bahamas Summit - Marketscreener.com

Oct 21, 2024
pulisher
Oct 18, 2024

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit - GlobeNewswire

Oct 18, 2024
pulisher
Oct 16, 2024

Check Out Oragenics Inc (OGEN)’s Trade Data Rather Than the Analysts’ Views - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Oragenics Shares Investor Presentation Online - TipRanks

Oct 16, 2024
pulisher
Oct 15, 2024

Oragenics inks sales agreement for at-the-market stock offering - Investing.com

Oct 15, 2024
pulisher
Oct 15, 2024

Oragenics inks sales agreement for at-the-market stock offering By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 15, 2024

Oragenics Inc (OGEN) stock analysis: A comprehensive overview - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

The Future of Oragenics Inc: Analyzing OGEN - The InvestChronicle

Oct 14, 2024
pulisher
Oct 09, 2024

Oragenics advances concussion treatment with ONP-002 By Investing.com - Investing.com South Africa

Oct 09, 2024
pulisher
Oct 09, 2024

Oragenics advances concussion treatment with ONP-002 - Investing.com India

Oct 09, 2024
pulisher
Oct 09, 2024

Metric Deep Dive: Understanding Oragenics Inc (OGEN) Through its Ratios - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation - GlobeNewswire

Oct 09, 2024
pulisher
Oct 08, 2024

OGEN stock touches 52-week low at $0.37 amid sharp annual decline - Investing.com India

Oct 08, 2024
pulisher
Oct 08, 2024

OGEN’s valuation metrics: A comprehensive analysis - US Post News

Oct 08, 2024
pulisher
Oct 08, 2024

Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002 - The Manila Times

Oct 08, 2024
pulisher
Oct 08, 2024

EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate - Yahoo Finance

Oct 08, 2024
pulisher
Oct 04, 2024

Naples Soap Company Announces Reverse Stock Split - Business Wire

Oct 04, 2024
pulisher
Oct 04, 2024

CDE STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Coeur Mining, Inc. Is Fair to Shareholders - Business Wire

Oct 04, 2024
pulisher
Oct 04, 2024

Ferguson Files Form 8-K and Prospectus Supplement to its Shelf Registration Statement - Business Wire

Oct 04, 2024
pulisher
Oct 03, 2024

Photo of Genesco Employees Fitting Students with New Shoes at Ida B. Wells Elementary School in Nashville Available on Business Wire's Website and the Associated Press Photo Network - Business Wire

Oct 03, 2024
pulisher
Oct 03, 2024

Webcast Alert: Olympic Steel to Announce Third-Quarter 2024 Financial Results After Market Closes on October 31, 2024 - Business Wire

Oct 03, 2024
pulisher
Oct 03, 2024

Reinsurance Group of America Announces Third Quarter Earnings Release Date, Webcast - Business Wire

Oct 03, 2024
pulisher
Oct 03, 2024

Graco Inc. Announces Third Quarter 2024 Earnings Conference Call - Business Wire

Oct 03, 2024
pulisher
Oct 01, 2024

Momentive Technologies Acquires Spherical Alumina and Spherical Silica Businesses From Sibelco - Business Wire

Oct 01, 2024
pulisher
Oct 01, 2024

Wellfit Technologies to Share Expert Insights on AADOM Radio: Demystifying Dental Financing for Profitability - Business Wire

Oct 01, 2024
pulisher
Sep 30, 2024

OGEN stock touches 52-week low at $0.38 amid sharp annual decline By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

OGEN stock touches 52-week low at $0.38 amid sharp annual decline - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Toyoda Gosei Invests in TriOrb Inc., a Startup Developing Mobile Robots With Omnidirectional Movement Capability - Business Wire

Sep 30, 2024
pulisher
Sep 30, 2024

LLAP Investors Have Opportunity to Lead Terran Orbital Corporation Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Sep 30, 2024
pulisher
Sep 27, 2024

Oragenics (AMEX:OGEN) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 27, 2024

Afya Limited to Host Afya Day 2024 on October 29th | Hybrid Event - Business Wire

Sep 27, 2024
pulisher
Sep 26, 2024

Expliseat Unveils an Ultra-Light Train Seat at Innotrans - Business Wire

Sep 26, 2024
pulisher
Sep 24, 2024

OGEN stock touches 52-week low at $0.47 amid sharp annual decline - Investing.com India

Sep 24, 2024
pulisher
Sep 21, 2024

Oragenics grants stock options to top executives - Investing.com India

Sep 21, 2024
pulisher
Sep 20, 2024

Oragenics grants stock options to top executives By Investing.com - Investing.com Canada

Sep 20, 2024
pulisher
Sep 20, 2024

Oragenics Executive Compensation and Shareholder Meeting Updates - TipRanks

Sep 20, 2024
pulisher
Sep 18, 2024

OutKick Delivers Strong Year Over Year Growth in August 2024 - Business Wire

Sep 18, 2024
pulisher
Sep 17, 2024

Oragenics Inc’s Market Journey: Closing Weak at 0.50, Down -6.08 - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

Sopra Steria Group: Disclosure of the Total Number of Shares and Voting Rights as at 31 August 2024 - Business Wire

Sep 17, 2024
pulisher
Sep 13, 2024

Deeper Dive: Understanding Oragenics Inc (OGEN) Through its Various Ratios - The Dwinnex

Sep 13, 2024
pulisher
Sep 13, 2024

Holdings of Oragenics Inc (OGEN) are aligned with the stars - SETE News

Sep 13, 2024
pulisher
Sep 12, 2024

OGEN stock touches 52-week low at $0.47 amid sharp yearly decline - Investing.com

Sep 12, 2024

Oragenics Inc Stock (OGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.30
price up icon 1.75%
$75.59
price down icon 0.20%
$374.10
price down icon 0.29%
$52.67
price down icon 0.85%
$207.67
price up icon 0.20%
$108.59
price up icon 0.02%
Cap:     |  Volume (24h):